These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 23633060)
1. Normality test is needed in data description: a neglectful but vital problem. Xing YF; Li X Kidney Int; 2013 May; 83(5):970-1. PubMed ID: 23633060 [No Abstract] [Full Text] [Related]
2. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels. Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171 [TBL] [Abstract][Full Text] [Related]
3. [Studies on the effects of lipoproteins and apoproteins on lipoprotein receptors. III. The comparison of normal and hyperlipidemic serum LDL in smooth muscle cells in the rabbit by the LDL receptor]. Hu YM; Xue H; Wu G Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep; 13(3):179-82, 239. PubMed ID: 4092597 [No Abstract] [Full Text] [Related]
4. [Mechanism of arteriosclerosis and hyperlipidemia]. Yamada N Nihon Naika Gakkai Zasshi; 1992 Nov; 81(11):1819-24. PubMed ID: 1479224 [No Abstract] [Full Text] [Related]
5. Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Liang K; Vaziri ND Kidney Int; 1999 Aug; 56(2):621-6. PubMed ID: 10432401 [TBL] [Abstract][Full Text] [Related]
7. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome. Vaziri ND; Liang K Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein and receptor interactions in vivo. Herz J; Willnow TE Curr Opin Lipidol; 1995 Apr; 6(2):97-103. PubMed ID: 7773575 [TBL] [Abstract][Full Text] [Related]
9. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409 [TBL] [Abstract][Full Text] [Related]
10. Developmental neurobiology. Decoding the Reelin signal. Bar I; Goffinet AM Nature; 1999 Jun; 399(6737):645-6. PubMed ID: 10385113 [No Abstract] [Full Text] [Related]
11. [Apolipoprotein E]. Xie YH; Wang KQ Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):136-41. PubMed ID: 2990024 [No Abstract] [Full Text] [Related]
12. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070 [TBL] [Abstract][Full Text] [Related]
13. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Vaziri ND Kidney Int; 2016 Jul; 90(1):41-52. PubMed ID: 27165836 [TBL] [Abstract][Full Text] [Related]
18. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome. Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448 [TBL] [Abstract][Full Text] [Related]
19. Low density lipoprotein peptide metabolism in nephrotic syndrome: a comparison with patterns observed in other syndromes characterised by hyperlipoproteinaemia. Scott PJ; White BM; Winterbourn CC; Hurley PJ Australas Ann Med; 1970 Feb; 19(1):1-15. PubMed ID: 5505516 [No Abstract] [Full Text] [Related]
20. Down-regulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. Sato T; Liang K; Vaziri ND Kidney Int; 2002 Jan; 61(1):157-62. PubMed ID: 11786096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]